Crunching the numbers for HIMS... Refresh in a moment for the full analysis.
Hims & Hers Health, Inc. (HIMS)
Healthcare
healthy
$19.14
Updated: 2026-04-12
65
TradeApes Score
add
Financial Strength
75
Strong
Operating Trend
73
Healthy
Valuation
65
Healthy
Capital Allocation
30
Weak
Risk
70
Healthy
Key Findings
+
Historically cheap — EV/EBITDA in bottom 25% of its 5-year range
−
Significant dilution — share count up more than 5% year over year
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.